Evidence map›Paper›PMID 23029384›Full record

ArticlePloS one2012

Uptake of biotin by Chlamydia Spp. through the use of a bacterial transporter (BioY) and a host-cell transporter (SMVT).

Derek J Fisher, Reinaldo E Fernández, Nancy E Adams, Anthony T Maurelli

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 46 citations in OpenAlex.

  1. Exploring the Link Between Biotin Metabolism andPathogens (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Article
  4. Journal of bacteriology · 2025
    Review
  5. Genome organization and genomics inFrontiers in cellular and infection microbiology · 2023
    Review
  6. Review
  7. Article
  8. Evolution ofPeerJ · 2020
    Article
  9. Article
  10. Make It a Sweet Home: Responses ofMicrobiology spectrum · 2019
    Review
  11. Review
  12. Chlamydial Infection From Outside to Inside.Frontiers in microbiology · 2019
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. The eukaryotic signal sequence, YGRL, targets the chlamydial inclusion.Frontiers in cellular and infection microbiology · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Derek J FisherDepartment of Microbiology, Southern Illinois University, Carbondale, United States of America.
Reinaldo E Fernández
Nancy E Adams
Anthony T Maurelli
Uniformed Services University of the Health Sciences · USSouthern Illinois University Carbondale · US

Funding

MOLECULAR GENETIC ANALYSIS OF CHLAMYDIA PATHOGENICITYR01AI044033 · NIAID · UNIVERSITY OF FLORIDA · PI MAURELLI, ANTHONY T · 1999 to 2016
$3.9M
Validating metabolic pathways in the intracellular pathogen Chlamydia trachomatisF32AI078655 · NIAID · HENRY M. JACKSON FDN FOR THE ADV MIL/MED · PI FISHER, DEREK JAMES · 2008 to 2010
$149k
NIAID NIH HHS F32 AI078655NIAID NIH HHS F32 AI078655-01NIAID NIH HHS R01 AI044033
6 · The paper itself

Abstract

Chlamydia spp. are obligate intracellular Gram-negative bacterial pathogens that cause disease in humans and animals. Minor variations in metabolic capacity between species have been causally linked to host and tissue tropisms. Analysis of the highly conserved genomes of Chlamydia spp. reveals divergence in the metabolism of the essential vitamin biotin with genes for either synthesis (bioF_2ADB) and/or transport (bioY). Streptavidin blotting confirmed the presence of a single biotinylated protein in Chlamydia. As a first step in unraveling the need for divergent biotin acquisition strategies, we examined BioY (CTL0613) from C. trachomatis 434/Bu which is annotated as an S component of the type II energy coupling-factor transporters (ECF). Type II ECFs are typically composed of a transport specific component (S) and a chromosomally unlinked energy module (AT). Intriguingly, Chlamydia lack recognizable AT modules. Using (3)H-biotin and recombinant E. coli expressing CTL0613, we demonstrated that biotin was transported with high affinity (a property of Type II ECFs previously shown to require an AT module) and capacity (apparent K(m) of 3.35 nM and V(max) of 55.1 pmol×min(-1)×mg(-1)). Since Chlamydia reside in a host derived membrane vacuole, termed an inclusion, we also sought a mechanism for transport of biotin from the cell cytoplasm into the inclusion vacuole. Immunofluorescence microscopy revealed that the mammalian sodium multivitamin transporter (SMVT), which transports lipoic acid, biotin, and pantothenic acid into cells, localizes to the inclusion. Since Chlamydia also are auxotrophic for lipoic and pantothenic acids, SMVT may be subverted by Chlamydia to move multiple essential compounds into the inclusion where BioY and another transporter(s) would be present to facilitate transport into the bacterium. Collectively, our data validates the first BioY from a pathogenic organism and describes a two-step mechanism by which Chlamydia transport biotin from the host cell into the bacterial cytoplasm.

Indexed as

Host-Pathogen InteractionsBacterial ProteinsBiological Transport, ActiveBiotinBiotinylationChlamydiaChlamydia InfectionsGenome, BacterialHeLa CellsHumansSymportersBacterial ProteinsBiotinbiotin transporterSymporters

Identifiers

PMID23029384
PMCPMC3459881
OpenAlexW2156305223

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.